[{"Assets_0_Q3_USD":141462000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-111903000.0,"NetIncomeLoss_1_Q3_USD":-58808000.0,"NetIncomeLoss_3_Q3_USD":-146743000.0,"StockholdersEquity_0_Q3_USD":12394000.0,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]